Videos

Rebecca T. Brown, MD, MPH, discusses the growing prevalence of older homeless adults, and what diseases community leaders and caregivers are combating most frequently in them.

Treatment adherence remains a concern in psychiatry.

Postpartum depression rates have increased since the COVID-19 pandemic.

Alcohol, stress, drug use, and not seeking help are all risk factors for chronic depression.

CBD has shown promise in treating anxiety and psychosis.

There remains a need for better treatments for bipolar disorder when it is identified early.

Mixed feature depression can be difficult to diagnose because the symptoms can be similar to other psychiatric disorders.

There remains a need for more research into the connection between grief and depression following a death.

Dr. Levine talks with Dr. Lisa Harding about how clinicians can best improve patient care in psychiatry.

The Duke expert reviews key strategies for starting and continuing care with the pivotal glycemic control agent.

ALT fluctuations remained stable for patients with NAFLD throughout disease progression.

An Ohio State researcher discusses a new medical center education program for navigating addiction risk in pain patients.

MM-120 is a pharmacologically optimized form of Lysergic acid diethylamide (LSD).

Travis Vandergriff, MD, discusses the unique collaboration with ophthalmologists and urologists in the rare skin condition.

The interventional pulmonology specialist discusses new technology and devices available for diagnosing lung cancer.

A dive into the manifestation of the rare skin condition, and the impactful role of dermatologists in diagnosing it early.

At HiD 2022, Dr. Budoff discusses the use and utility of coronary calcium scoring for risk stratification

Savanna Perry, PA-C, discussed the challenge of standing out over influencers and estheticians regarding clinical dermatology insight, and the unique offerings of different platforms.

Savanna Perry, PA-C, founder of The PA Platform, discusses the strategies and goals that go into building an online audience as a healthcare professional.

Dr. Cohen details the latest study from Yale, which indicated that women from lichen sclerosus had increased risk of developing depression and anxiety.

Dr. Gadani often suggests patients eat smaller meals and do not eat too close to bedtime.

Dr. Lisa Arkin speaks to how evidence-based, expert opinion-led consensus treatment plans for scleroderma can help change the way patients and providers approach the disease.

Dr. Cordoro speaks on the prevalence of variants of scleroderma in children, and how provides can better recognize and treat the disease in pediatric populations.

Mark Blumberg, MD, discusses his laboratory's particular interest in early REM sleep movement, and its potential impact on neurological disorders.

The late-breaking data show SGLT2is are underutilized in patients with heart failure with or without type 2 diabetes despite guideline recommendations.

The diabetologist and professor discusses new findings from the ReTUNE trial, which disparage the utility of BMI in defining diabetes risk and remission opportunity.

In recent years more and more biologics have come on the market for the treatment of IBD.

A Montefiore residency director explains the impact of engaging with communities to improve mental health care capability.